Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Sunfish Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2020 Founded
Tractionpublic signals, read monthly
GitHub stars
8 public repositories
Registers and programsofficial lists and records that name the company
Legal entity Deepflare sp. z o.o. its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
ReNewVax logoFounded 2022
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
BaseimmuneSeries A $11.3M · 2 yr ago • Founded 2019 • 11-50 employees
404 Err….or The vaccines you're looking for don't exist. Yet….
Apriori BioFounded 2020
Protecting against viral threats. Ushering in a new era of AI-enabled vaccine design.
GIVAX51-200 employees
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…
NeoVac Pre-Seed11-50 employees
NeoVac is creating revolutionary, unique and proprietary next-generation lipid nanoparticles.
Infinitopes Precision Immunomics™Founded 2018 • 11-50 employees
Positioned to deliver revolutionary off-the-shelf cancer vaccines. OUR CORE MISSION.

Overview

Deepflare predicts true T-cell immunogenicity with 12x greater accuracy than standard tools. Design next-generation antigen candidates for vaccines and immunotherapies.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Warsaw Poland
Regional office
Talk to Deepflare
ul. Złota 7/2800-019 Warszawa, Poland
company site